Litwińska B, Bucholc B, Biesiadecka A, Kańtoch M
Zakład Wirusologii PZH w Warszawie.
Med Dosw Mikrobiol. 1993;45(4):523-8.
Preparations of human immunoglobulins for intravenous use (IVIG) should contain proper percentage of IgG subclasses, responding to physiological preparations with preserved activity of antibodies. The study was aimed at establishment of activity against measles, CMV and HSV viruses in individual subclasses of Bioglobulin (Biomed, Warszawa) and a comparison with preparation Polygam (Baxter, USA). Indirect immunofluorescence test was used. The results revealed presence of antiviral activity mostly in subclass IgG1 and also in IgG3, which is in keeping with results obtained by other authors. We have found an anti-HSV activity in a subclass IgG2 and IgG4 in IVIG preparations which was not yet described in the literature; it is confirmed, however, in investigations with application of sera of HSV-positive persons. These discrepancies may be caused by different methods of detection. Viral antigens in ELISA and IF tests may differ among themselves by content of individual epitopes. Basing on obtained results it can be stated that Polish preparation Bioglobulin (in which for the first time antiviral activity was determined in subclasses) is comparable with Polygam.
静脉用人免疫球蛋白(IVIG)制剂应含有适当比例的IgG亚类,以模拟具有抗体活性的生理制剂。本研究旨在确定Bioglobulin(Biomed,华沙)各亚类对麻疹、巨细胞病毒(CMV)和单纯疱疹病毒(HSV)的活性,并与美国百特公司生产的Polygam制剂进行比较。采用间接免疫荧光试验。结果显示抗病毒活性主要存在于IgG1亚类,IgG3亚类也有活性,这与其他作者的研究结果一致。我们在IVIG制剂的IgG2和IgG4亚类中发现了抗HSV活性,这在文献中尚未见报道;然而,在对HSV阳性者血清的研究中得到了证实。这些差异可能是由不同的检测方法引起的。ELISA和IF试验中的病毒抗原可能因各自表位的含量不同而有所差异。基于所得结果,可以说波兰的Bioglobulin制剂(首次在亚类中测定了抗病毒活性)与Polygam相当。